Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.04 - $4.23 $93,328 - $129,861
30,700 New
30,700 $124,000
Q4 2022

Feb 14, 2023

SELL
$1.75 - $3.96 $19,950 - $45,144
-11,400 Reduced 23.46%
37,200 $84,000
Q3 2022

Nov 14, 2022

BUY
$3.09 - $7.46 $150,174 - $362,556
48,600 New
48,600 $153,000
Q2 2022

Aug 15, 2022

SELL
$1.92 - $6.28 $93,312 - $305,208
-48,600 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$5.07 - $7.2 $110,019 - $156,240
21,700 Added 80.67%
48,600 $292,000
Q4 2021

May 03, 2022

BUY
$5.67 - $8.54 $152,523 - $229,725
26,900 New
26,900 $173,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $238M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.